Progress Born From a Legacy of Collaboration

摘要: This Special Series issue of Journal Clinical Oncology highlights collaborative efforts that have contributed to the remarkable progress achieved in advancing survival for pediatric cancers. These involved collaborations across a variety medical subspecialties, institutions, and national international cooperative study groups and, most importantly, among clinicians, scientists, patients their families. Unique cancer experience is high level participation clinical trials has been instrumental establishing effective therapies virtually all types cancers; characterizing acute, long-term, late-onset toxicities therapy; refining treatment approaches adapted biologic characteristics disease; recent decades, modifying therapy prevent treatment-related adverse effects. Particularly featured within this series are innovative genomic discoveries guided risk-adapted stratification use targeted providing real prospects precision medicine.